[1]
S. Saha and S. . Saha, “A systematic review and meta-analysis of randomized controlled trials, juxtaposing the control of glycemia and blood pressure between large dose empagliflozin and placebo among type 1 diabetes patients”, IJHS, vol. 14, no. 2, Feb. 2020.